Das Problem Statin-assoziierter Muskelschmerzen und damit die Sorge, dass Ihrem Patienten das präventive Potenzial der Statintherapie entgeht, kennen Sie sicherlich auch. Der nachfolgende Beitrag zeigt auf, wie Sie das Problem Schritt für Schritt in den Griff bekommen.
Literatur
Yusuf S, Why do people not take life-saving medications? The case of statins. Lancet. 2016 Sep 3;388(10048):943–5
Collins R et al., Interpretation of the evidence for the efficacy and safety of statin therapy. Lancet. 2016 Nov 19;388(10059):2532–2561
Stroes ES et al., Statin-associated muscle symptoms: impact on statin therapy-European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management. Eur Heart J. 2015 May 1;36(17):1012–22
Hovingh GK et al., Identification and management of patients with statin-associated symptoms in clinical practice: A clinician survey. Atherosclerosis. 2016 Feb;245:111–7
Laufs U et al, Behandlungsoptionen bei Statin-assoziierten Muskelbeschwerden. Dtsch Ärztebl Int. 2015 Oct 30;112(44):748–55
Parker BA et al., Effect of statins on skeletal muscle function. Circulation. 2013 Jan 1;127(1):96–103
Moriarty PM et al., Efficacy and safety of alirocumab vs ezetimibe in statin-intolerant patients, with a statin rechallenge arm: The ODYSSEY ALTERNATIVE randomized trial. J Clin Lipidol. 2015 Nov-Dec;9(6):758–769
Nissen SE et al., Efficacy and Tolerability of Evolocumab vs Ezetimibe in Patients With Muscle-Related Statin Intolerance: The GAUSS-3 Randomized Clinical Trial. JAMA. 2016 Apr 19;315(15):1580–90
Gupta A et al., Adverse events associated with unblinded, but not with blinded, statin therapy in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid-Lowering Arm (ASCOT-LLA): a randomised double-blind placebo-controlled trial and its non-randomised non-blind extension phase. Lancet. 2017 Jun 24;389(10088):2473–2481
2014 arznei-telegramm, publiziert am 9. Mai 2014
Laufs U et al., Practical aspects in the management of statin-associated muscle symptoms (SAMS). Atheroscler Suppl. 2017 Apr;26:45–55
du Souich P et al, Myotoxicity of statins: Mechanism of action. Pharmacol Ther. 2017 Jul;175:1–16
Cholesterol Treatment Trialists’ (CTT) Collaboration, Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet. 2010 Nov 13;376(9753):1670–81
Daskalopoulou SS et al, Discontinuation of statin therapy following an acute myocardial infarction: a population-based study. Eur Heart J. 2008 Sep;29(17):2083–91
Shalev V et al., Continuation of statin treatment and all-cause mortality: a population-based cohort study. Arch Intern Med. 2009 Feb 9;169(3):260–8
Turner RM et al., Investigating the prevalence, predictors, and prognosis of suboptimal statin use early after a non-ST elevation acute coronary syndrome. J Clin Lipidol. 2017 Jan - Feb;11(1):204–214
Serban MC et al., Statin Intolerance and Risk of Coronary Heart Events and All-Cause Mortality Following Myocardial Infarction. J Am Coll Cardiol. 2017 Mar 21;69(11):1386–1395
Nissen SE, Statin Denial: An Internet-Driven Cult With Deadly Consequences. Ann Intern Med. 2017 Aug 15;167(4):281–282
Nielsen SF et al., Negative statin-related news stories decrease statin persistence and increase myocardial infarction and cardiovascular mortality: a nationwide prospective cohort study. Eur Heart J. 2016 Mar 14;37(11):908–916
Landmesser, U et al., 2017 Update of ESC/EAS Task Force on practical clinical guidance for proprotein convertase subtilisin/kexin type 9 inhibition in patients with atherosclerotic cardiovascular disease or in familial hypercholesterolaemia. Eur Heart J. 2017 Oct 16 doi: 10.1093/eurheartj/ehx549. [Epub ahead of print
Irvin JC The effect of lipophilicity and dose on the frequency of statin-associated muscle symptoms: A systematic review and meta-analysis. Pharmacological Research 2017
Khayznikov M et al., Statin Intolerance Because of Myalgia, Myositis, Myopathy, or Myonecrosis Can in Most Cases be Safely Resolved by Vitamin D Supplementation. N Am J Med Sci. 2015 Mar;7(3):86–93
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Klose, G. Sechs Maßnahmen bei Statin-assoziierten Muskelschmerzen. MMW - Fortschritte der Medizin 160, 40–43 (2018). https://doi.org/10.1007/s15006-018-0090-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s15006-018-0090-3